You've seen the threads. "It changed my life." "Didn't do anything for me." "Took 3 months to notice anything." Inositol is the most-discussed supplement in PCOS/PMOS spaces — myo-inositol, d-chiro-inositol, the 40:1 ratio, cycling it. Every forum, every subreddit, every Facebook group has at least one inositol thread running at any given moment.
But almost nobody tracks whether it's actually changing their patterns.
Most people either feel broadly "better" and assume it's working, or give up after 6 weeks because nothing seems to have shifted. Both outcomes miss the data. The problem isn't the supplement — it's that without a baseline and a measurement framework, you have no way to know what "working" even means for your body.
Inositol is a naturally occurring compound involved in insulin signalling. In PCOS/PMOS, insulin resistance disrupts the conversion of myo-inositol to d-chiro-inositol in target tissues, impairing glucose uptake and driving the androgen cascade. Supplementing the 40:1 myo:d-chiro ratio attempts to restore this. But "working" means different things depending on which system you're asking about: insulin sensitivity, ovarian function, androgen levels, cycle regularity, energy, cravings — and they don't all respond at the same speed.
This post is about how to know if inositol is actually doing anything for you.
The Biology: What Inositol Is Actually Doing
To understand what to track, you first need to understand what inositol is trying to fix.
Myo-inositol and the PI3K/Akt pathway
Myo-inositol is a secondary messenger in the insulin signalling cascade — specifically in the PI3K/Akt pathway that handles GLUT4 translocation, the process by which glucose gets into cells. In PCOS/PMOS, reduced myo-inositol availability in the ovaries and muscle tissue impairs this pathway. Insulin can't do its job properly. Glucose stays in the bloodstream longer than it should. The pancreas compensates by producing more insulin. Chronically elevated insulin then drives the androgen cascade — which is where the acne, hair growth, cycle disruption, and weight resistance come from.
D-chiro-inositol and glycogen synthesis
D-chiro-inositol acts as a co-factor in glycogen synthesis — the process of storing glucose in muscle tissue. This matters because muscle glycogen is a key buffer against reactive hypoglycaemia: the blood sugar drop that follows a meal, driving cravings and energy crashes 60–90 minutes after eating. When glycogen synthesis is impaired, that buffer is smaller, and the crash is sharper.
Why the 40:1 ratio matters
The 40:1 myo-inositol to d-chiro-inositol ratio isn't arbitrary. The ovaries need primarily myo-inositol — too much d-chiro-inositol can actually impair oocyte quality by over-activating the d-chiro pathway locally. Most clinical trials use 2g myo-inositol plus 50mg d-chiro-inositol twice daily, taken with food.
Timeline is everything
This is the piece nobody says clearly enough: different systems respond at different speeds. Insulin sensitivity changes can appear in 4–8 weeks. Cycle regularity takes 3–6 months. Androgen-related symptoms — acne, hair loss, excess hair growth — take 6–12 months because they depend on androgens falling, which depends on the ovarian pathway normalising, which is downstream of insulin sensitivity improving.
Most people give up at week 6, right before the first signals would become visible. They miss the data entirely.
What Your Atlas Check-In Data Is Telling You (5 Signals)
If inositol is working, these are the places you'll see it first.
1. Energy after meals
If inositol is improving insulin signalling, the 90-minute post-meal energy crash should reduce. This is the fastest-responding signal — insulin sensitivity improvements show up here within 4–8 weeks. Track your energy at T+90min after your main meals and look for the crash becoming shallower over 6–8 weeks. Not gone — shallower. A consistent reduction in the depth of the post-meal dip is a real signal.
2. Evening cravings
Reactive hypoglycaemia drives the evening sugar pull. You eat dinner, blood glucose drops, insulin overshoots, and your brain demands sugar at 9pm. As insulin sensitivity improves, baseline glucose stability increases and the drop becomes less severe. If you're logging evening craving intensity, look for late-evening ratings trending downward over 4+ weeks. This is one of the clearest early markers. There's a full breakdown of why PCOS/PMOS bodies experience this pull in this post on night sugar cravings.
3. Cycle day logging
Cycle length and regularity are a direct readout of ovarian function and LH/FSH balance. If inositol is improving the ovarian insulin pathway, you should see cycle length moving toward a tighter, more predictable range over 3–6 months — for example, from 45+ days toward 28–35 days, or from highly variable (35 days, then 52, then 40) toward consistent. Log your cycle start dates and track the trajectory across at least 3 consecutive cycles.
4. Cycle day vs energy and cravings
In PCOS/PMOS, the follicular phase — roughly days 7–14 — can be indistinct: your hormonal profile is dysregulated enough that the low-symptom window most women experience around ovulation either doesn't appear or is hard to identify. As oestrogen production normalises with improved ovarian function, that window should become clearer. Track: is there an emerging period of lower cravings and higher energy in the week after your period ends? That's the follicular improvement signal.
5. Skin flag and cycle day overlay
Androgen-driven acne — typically chin and jaw — responds slowly. This is a 3–6 month signal, not a 6-week one. But if you're logging skin flares alongside cycle day, you can start to see whether breakouts are clustering on fewer cycle days over time, or whether their frequency is reducing. The trajectory matters more than any single data point.
> "Inositol doesn't work like a painkiller. It works like compound interest — and you need data to see it accumulating."
Three Patterns Worth Tracking Over 8+ Weeks
Post-meal energy trend
Log your energy at T+90min — approximately 90 minutes after your main meal — consistently. Ideally, start this 4 weeks before beginning inositol so you have a genuine baseline. A meaningful signal is a 0.5-point or greater improvement in average T+90 energy over 8 weeks of supplementation. This is the fastest-responding marker and the one most likely to give you an early indication that something is shifting.
Evening craving baseline shift
Compare your average late-evening craving rating — around 8–9pm — in weeks 1–2 of tracking versus weeks 7–8. A downward shift of 1 point or more, with broadly stable food composition across both periods, suggests improved glucose stability. This is important: if your diet has changed significantly between the two periods, the craving shift might be diet-driven rather than inositol-driven. Hold the food composition roughly constant to isolate the signal.
Cycle length trajectory
Plot your cycle lengths across 3 consecutive cycles. If you're moving from 40+ days toward 28–35 days, or from irregular to consistent, that's the clearest ovarian function signal available. This takes longer to emerge — don't assess it at 8 weeks. Assess it at 12–16 weeks minimum.
Atlas's pattern engine compares these trends automatically — you don't have to build the spreadsheet.
What to Do With the Insight
Three experiments to run
First: log a 4-week baseline before starting inositol. If you're already tracking in Atlas, your existing data serves as the retrospective baseline. Then begin 2g myo-inositol plus 50mg d-chiro-inositol twice daily, taken with food. The twice-daily dosing matters — a single large dose is less effective than splitting it.
Second: take it consistently. Missing doses doesn't just mean less benefit — it disrupts the signal and makes interpretation impossible. If you're trying to assess whether inositol is working, you need clean data. That means consistent dosing over the assessment period.
Third: assess at the right intervals. At 8 weeks, compare post-meal energy and evening cravings against your baseline. At 12 weeks, compare cycle length trajectory. Don't make a final call at 6 weeks — that's before the cycle signal would even be visible.
Framing the GP conversation
If you've been tracking and you have 8 weeks of trend data, bring it. The framing that opens doors: "My post-meal energy has improved by X on average and my evening cravings have reduced — I think inositol is improving my insulin response. Can we run a fasting insulin and HOMA-IR to confirm?" This positions you as a pattern-informed patient working from data, not someone self-treating based on a forum thread.
A HOMA-IR score comparing your baseline to 8 weeks of supplementation gives you an objective marker that complements the subjective data. Some GPs are receptive to this framing; others aren't. Either way, having the data makes the conversation more productive.
If you're already on metformin or considering it alongside inositol, this post on what to track to know if metformin is working covers the same pattern-tracking approach for that medication.
If there's no signal at 12 weeks
That's also data. Inositol works primarily on the insulin resistance pathway. If the primary driver of your PCOS/PMOS isn't insulin resistance — if it's cortisol dysregulation, thyroid dysfunction, or a different hormonal imbalance — inositol alone won't move the needle significantly.
If you're tracking and you see no change in post-meal energy, no change in evening cravings, and no cycle trend shift after 12 weeks of consistent dosing, consider whether the evidence points toward a different primary mechanism. This post on why the calories in/out model fails covers the cortisol and thyroid pathways that operate independently of insulin. This post on PCOS/PMOS and stress goes deeper on the HPA axis pathway specifically.
For the next-line pharmacological option, see the metformin tracking post linked above. Inositol and metformin work on overlapping but distinct parts of the insulin pathway — some women respond better to one, some to both in combination.
Most people never know if inositol worked. They took it for a few weeks, felt vaguely better or vaguely nothing, and stopped. They have no data either way.
You will.
Start Atlas — track whether inositol is actually working for your body.